10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2012 | |||
Consolidated Statements of Earnings | |||
Period Ending Dec 30, 2012 10-K (Filed: Feb 22, 2013) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 30, 2012 | Jan 1, 2012 | Jan 2, 2011 | |
| Sales to customers | $ 67,224 | 65,030 | 61,587 |
| Cost of products sold | 21,658 | 20,360 | 18,792 |
| Gross profit | 45,566 | 44,670 | 42,795 |
| Selling, marketing and administrative expenses | 20,869 | 20,969 | 19,424 |
| Research and development expense | 7,665 | 7,548 | 6,844 |
| In-process research and development | 1,163 | 0 | 0 |
| Interest income | (64) | (91) | (107) |
| Interest expense, net of portion capitalized | 532 | 571 | 455 |
| Other (income) expense, net | 1,626 | 2,743 | (768) |
| Restructuring expense | 0 | 569 | 0 |
| Earnings before provision for taxes on income | 13,775 | 12,361 | 16,947 |
| Provision for taxes on income | 3,261 | 2,689 | 3,613 |
| Net Earnings | 10,514 | 9,672 | 13,334 |
| Add: Net Loss Attributable to Noncontrolling Interest | 339 | 0 | 0 |
| Net earnings attributable to Johnson & Johnson | 10,853 | 9,672 | 13,334 |
| Net earnings per share attributable to Johnson & Johnson | |||
| Basic | 3.94 | 3.54 | 4.85 |
| Diluted | 3.86 | 3.49 | 4.78 |
| Cash dividends per share | 2.40 | 2.25 | 2.11 |
| Average shares outstanding | |||
| Basic | 2,753,300 | 2,736,000 | 2,751,400 |
| Diluted | 2,812,600 | 2,775,300 | 2,788,800 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2012 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 30, 2012 10-K (Filed: Feb 22, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 30, 2012 | Jan 1, 2012 | Jan 2, 2011 | |
| Net Earnings | $ 10,514 | 9,672 | 13,334 |
| Other Comprehensive Income (Loss), net of tax | |||
| Foreign currency translation | 1,230 | (557) | (461) |
| Securities | |||
| Unrealized holding gain (loss) arising during period | (248) | 565 | 99 |
| Reclassification to earnings | (5) | (141) | (45) |
| Net change | (253) | 424 | 54 |
| Employee benefit plans | |||
| Prior service cost amortization during period | 2 | 5 | 4 |
| Prior service cost current year | (8) | 15 | 0 |
| Gain (loss) amortization during period | 370 | 246 | 188 |
| Gain (loss) - current year | (1,643) | (1,984) | (203) |
| Effect of exchange rates | (52) | 18 | (10) |
| Net change | (1,331) | (1,700) | (21) |
| Derivatives & hedges | |||
| Unrealized gain (loss) arising during period | 52 | (500) | (333) |
| Reclassifications to earnings | 124 | 232 | 288 |
| Net change | 176 | (268) | (45) |
| Other Comprehensive Income (Loss) | (178) | (2,101) | (473) |
| Total comprehensive income | 10,336 | 7,571 | 12,861 |
| Comprehensive Loss Attributable To Noncontrolling Interest, net of tax | 339 | 0 | 0 |
| Comprehensive Income Attributable To Johnson & Johnson | 10,675 | 7,571 | 12,861 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2012 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 30, 2012 10-K (Filed: Feb 22, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 30, 2012 | Jan 1, 2012 | Jan 2, 2011 | |
| CASH FLOW FROM OPERATING ACTIVITIES | |||
| Net Earnings | $ 10,514 | 9,672 | 13,334 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 3,666 | 3,158 | 2,939 |
| Stock based compensation | 662 | 621 | 614 |
| Noncontrolling interest | 339 | 0 | 0 |
| Asset write-downs and impairments | 2,131 | 160 | 0 |
| Deferred tax provision | (39) | (836) | 356 |
| Accounts receivable allowances | 92 | 32 | 12 |
| Changes in assets and liabilities, net of effects from acquisitions: | |||
| Increase in accounts receivable | (9) | (915) | (207) |
| Increase in inventories | (1) | (715) | (196) |
| Increase in accounts payable and accrued liabilities | 2,768 | 493 | 20 |
| Increase in other current and non-current assets | (2,172) | (1,785) | (574) |
| (Decrease)/Increase in other current and non-current liabilities | (2,555) | 4,413 | 87 |
| NET CASH FLOWS FROM OPERATING ACTIVITIES | 15,396 | 14,298 | 16,385 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Additions to property, plant and equipment | (2,934) | (2,893) | (2,384) |
| Proceeds from the disposal of assets | 1,509 | 1,342 | 524 |
| Acquisitions, net of cash acquired | (4,486) | (2,797) | (1,269) |
| Purchases of investments | (13,434) | (29,882) | (15,788) |
| Sales of investments | 14,797 | 30,396 | 11,101 |
| Other (primarily intangibles) | 38 | (778) | (38) |
| NET CASH USED BY INVESTING ACTIVITIES | (4,510) | (4,612) | (7,854) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Dividends to shareholders | (6,614) | (6,156) | (5,804) |
| Repurchase of common stock | (12,919) | (2,525) | (2,797) |
| Proceeds from short-term debt | 3,268 | 9,729 | 7,874 |
| Retirement of short-term debt | (6,175) | (11,200) | (6,565) |
| Proceeds from long-term debt | 45 | 4,470 | 1,118 |
| Retirement of long-term debt | (804) | (16) | (32) |
| Proceeds from the exercise of stock options/excess tax benefits | 2,720 | 1,246 | 1,226 |
| Other | (83) | 0 | 0 |
| NET CASH USED BY FINANCING ACTIVITIES | (20,562) | (4,452) | (4,980) |
| Effect of exchange rate changes on cash and cash equivalents | 45 | (47) | (6) |
| (Decrease)/increase in cash and cash equivalents | (9,631) | 5,187 | 3,545 |
| Cash and Cash equivalents, beginning of period | 24,542 | 19,355 | |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 14,911 | 24,542 | 19,355 |
| Supplemental schedule of non-cash investing and financing activities | |||
| Interest Paid | 616 | 576 | 491 |
| Income Taxes Paid | 2,507 | 2,970 | 2,442 |
| Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds | 615 | 433 | 673 |
| Debt Conversion, Converted Instrument, Amount | 0 | 1 | 1 |
| Acquisitions | |||
| Fair value of assets acquired | 19,025 | 3,025 | 1,321 |
| Fair value of liabilities assumed and non-controlling interests | (1,204) | (228) | (52) |
| Net fair value of acquisitions | 17,821 | 2,797 | 1,269 |
| Net cash paid for aquisitions | 4,486 | 2,797 | 1,269 |
| Statement, Business Segments | |||
| Synthes, Inc | |||
| Issuance of common stock associated with the acquisition of Synthes | 13,335 | 0 | 0 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2012 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 30, 2012 10-K (Filed: Feb 22, 2013) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 30, 2012 | Jan 1, 2012 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 14,911 | 24,542 |
| Marketable securities (Notes 1 and 2) | 6,178 | 7,719 |
| Accounts receivable, trade, less allowances for doubtful accounts $466 (2011, $361) | 11,309 | 10,581 |
| Inventories (Notes 1 and 3) | 7,495 | 6,285 |
| Deferred taxes on income (Note 8) | 3,139 | 2,556 |
| Prepaid expenses and other receivables | 3,084 | 2,633 |
| Total current assets | 46,116 | 54,316 |
| Property, plant and equipment, net (Notes 1 and 4) | 16,097 | 14,739 |
| Intangible assets, net (Notes 1 and 5) | 28,752 | 18,138 |
| Goodwill (Notes 1 and 5) | 22,424 | 16,138 |
| Deferred taxes on income (Note 8) | 4,541 | 6,540 |
| Other assets | 3,417 | 3,773 |
| Total assets | 121,347 | 113,644 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Loans and notes payable (Note 7) | 4,676 | 6,658 |
| Accounts payable | 5,831 | 5,725 |
| Accrued liabilities | 7,299 | 4,608 |
| Accrued rebates, returns and promotions | 2,969 | 2,637 |
| Accrued compensation and employee related obligations | 2,423 | 2,329 |
| Accrued taxes on income | 1,064 | 854 |
| Total current liabilities | 24,262 | 22,811 |
| Long-term debt | 11,489 | 12,969 |
| Deferred taxes on income (Note 8) | 3,136 | 1,800 |
| Employee related obligations (Notes 9 and 10) | 9,082 | 8,353 |
| Other liabilities | 8,552 | 10,631 |
| Total liabilities | 56,521 | 56,564 |
| Shareholders' equity: | ||
| Preferred stock - without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock - par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (5,810) | (5,632) |
| Retained earnings | 85,992 | 81,251 |
| Stockholders' Equity before Treasury Stock | 83,302 | 78,739 |
| Less: common stock held in treasury, at cost (Note 12) (341,354,000 and 395,480,000 shares) | 18,476 | 21,659 |
| Total shareholders' equity | 64,826 | 57,080 |
| Total liabilities and shareholders' equity | 121,347 | 113,644 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |